Elan's Irish Tax Base Becomes Perrigo's Pot of Gold

Elan's Irish Tax Base Becomes Perrigo's Pot of Gold Play

July 29 (Bloomberg) -- Bloomberg's Olivia Sterns reports on the $8.6 billion by Perrigo Co. to purchase Irish drug company Elan Corp. and the tax relief Ireland's tax-base may bring to the drugmaker, plus a look at what may be a split of internal operations by Pfizer. She speaks on Bloomberg Television's "Market Makers."

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus